| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 08/18/2011 | US20110201610 Aryl sulfonamides |
| 08/17/2011 | EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/16/2011 | US7999090 Fungal cell wall synthesis gene |
| 08/16/2011 | US7998977 Inhibitors of AKT (protein kinase B) |
| 08/16/2011 | CA2557163C Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 08/11/2011 | WO2011094953A1 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 08/11/2011 | US20110195978 Compounds for treatment of alzheimer's disease |
| 08/11/2011 | US20110195939 Antitumor properties of no modified protease inhibitors |
| 08/11/2011 | US20110195018 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists |
| 08/10/2011 | CN102149685A Isoquinolinone derivatives as NK3 antagonists |
| 08/09/2011 | US7994109 Organic catalyst with enhanced solubility |
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190330 Spirocyclic gpr40 modulators |
| 08/04/2011 | US20110185796 Cisatracurium derivatives, preparation and uses thereof |
| 08/03/2011 | EP2350015A1 Isoquinolinone derivatives as nk3 antagonists |
| 08/03/2011 | EP2349308A1 Compounds for treatment of alzheimer's disease |
| 08/03/2011 | CN102143950A Process for synthesizing substituted isoquinolines |
| 08/02/2011 | US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders |
| 08/02/2011 | US7989626 Modulators of cellular adhesion |
| 07/28/2011 | WO2011088536A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | CA2787684A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases |
| 07/27/2011 | EP2346830A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/27/2011 | EP2099764B1 Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
| 07/27/2011 | CN1930139B Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 07/27/2011 | CN102134245A Tetralin isoquinoline compounds as well as preparation methods and applications thereof |
| 07/21/2011 | WO2011086377A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| 07/21/2011 | US20110178083 Pde-10 inhibitors |
| 07/21/2011 | US20110178074 Antipathogenic benzamide compounds |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/20/2011 | EP2344481A2 Viral and fungal inhibitors |
| 07/20/2011 | EP2344472A1 Isoquinolinone derivatives |
| 07/20/2011 | EP2344456A1 Novel potassium channel blocker |
| 07/20/2011 | EP2344446A1 S1p receptors modulators |
| 07/20/2011 | EP1994005B1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 07/20/2011 | CN102131785A 6-substituted isoquinolines and isoquinolinones |
| 07/20/2011 | CN102131784A Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 07/20/2011 | CN102127097A N-(3S-1, 2, 3, 4- tetrahydroisoquinoline-3-formoxyl) cupric amino-acid complex, preparation method and application of complex |
| 07/19/2011 | US7981883 Substituted spiro-compounds and the use thereof for producing medicaments |
| 07/19/2011 | CA2553789C Sulfonamide derivatives for the treatment of diseases |
| 07/19/2011 | CA2432464C Excitatory amino acid receptor antagonists |
| 07/19/2011 | CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids |
| 07/14/2011 | WO2011082700A1 A method for the preparation of 6,7-dimethoxy-1-[2-(4-trifluoromethylphenyl)ethyl]-3,4- dihydroisoquinoline |
| 07/14/2011 | US20110172174 Antibacterial agents |
| 07/13/2011 | EP2342182A1 Isoquinolinone derivatives as nk3 antagonists |
| 07/13/2011 | CN102120727A N-[(3S)-N-aminoacyl-1,2,3,4-tetrahydroisoquinoline-3-formacyl]amino acid and synthesis method and application thereof |
| 07/12/2011 | CA2422617C Tripeptidyl peptidase inhibitors |
| 07/07/2011 | US20110166349 Gold catalyzed hydroamination of alkynes and allenes |
| 07/07/2011 | US20110166139 Pyridine compounds |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/06/2011 | EP1442094B1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 07/06/2011 | CN1777577B Antibacterial agents |
| 07/06/2011 | CN102115459A Preparation method of Tilisolol hydrochloride and intermediate thereof 4-hydroxyl-2-methyl-1-isoquinolone |
| 07/06/2011 | CN101037411B Splitting method of tetrahydroisoquinoline racemes |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 06/30/2011 | WO2011076786A1 Substituted isoquinolinones and quinazolinones |
| 06/30/2011 | WO2011075957A1 Tetrahydroisoquinoline compounds, preparation methods and uses thereof |
| 06/30/2011 | US20110160186 Methods of Treating CYP2D6 Alternative Metabolizers |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2041094B1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 06/29/2011 | EP1499313B1 Heterocyclic derivatives as opioid receptor modulators |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/23/2011 | US20110152220 Methods of diagnosing, preventing and treating bone mass diseases |
| 06/23/2011 | US20110148292 Organic compound and organic light-emitting device using the same |
| 06/22/2011 | CN101198591B Process of producing bleach boosters |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964613 Sulfonamide compound |
| 06/21/2011 | US7964204 Isoxazolines for controlling invertebrate pests |
| 06/15/2011 | EP2332917A1 Compounds for PIM kinase inhibition and for treating malignancy |
| 06/15/2011 | EP2331508A2 Substituted berbines and processes for their synthesis |
| 06/15/2011 | EP2331499A1 Cold menthol receptor antagonists |
| 06/15/2011 | CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 06/14/2011 | US7960398 Potent inhibitors of TNF activity |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/09/2011 | WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/09/2011 | US20110136859 Compounds |
| 06/09/2011 | US20110136845 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 06/09/2011 | US20110136842 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers |
| 06/09/2011 | US20110135599 Antiviral compounds |
| 06/09/2011 | CA2778586A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/08/2011 | EP2328871A2 Hedgehog pathway modulators |
| 06/08/2011 | EP1879895B1 Enzyme inhibitors |
| 06/08/2011 | CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 06/08/2011 | CN102088851A Chemical compounds |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/03/2011 | WO2011063773A2 Crystalline and amorphous forms of almorexant and a method of their preparation |
| 06/02/2011 | US20110130568 Acylsulfonamides and Processes for Producing the Same |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130431 Compounds Which Modulate The CB2 Receptor |
| 06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
| 06/01/2011 | EP2326624A2 Process for synthesizing substituted isoquinolines |
| 06/01/2011 | EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |